Literature DB >> 29275087

Gas chromatography-mass spectrometry metabolomic study of lipopolysaccharides toxicity on rat basophilic leukemia cells.

Fangchao Cui1, Pei Zhu2, Jian Ji1, Ivana Blaženović3, Morteza Gholami4, Yinzhi Zhang1, Xiulan Sun5.   

Abstract

Lipopolysaccharide (LPS) can lead to uncontrollable cytokine production, fatal sepsis syndrome and depression/multiple organ failure, as pathophysiologic demonstration. Various toxic effects of LPS have been extensively reported, mainly on the toxicity of LPS in cellular level, macrophages or tumor cells, etc. This work aimed on the impact of LPS on mast cell metabolism, which focused on LPS-induced cellular metabolic profiles. Gas chromatography-mass spectrometry (GC-MS) based metabolomics strategy was implemented for the endo-metabolites detection in rat basophilic leukemia (RBL-2H3) cells, treated with 10 μg/mL LPS for 24 h, along with multiple time-dose tests of cells viability/apoptosis. Significantly changes metabolites were mainly involved the metabolism of glycine, serine, threonine and the biosynthesis of phenylalanine, tyrosine, tryptophan and pentose phosphate pathway. The endo-metabolism results illustrated that LPS treatment led to downregulation of glycine, serine and threonine metabolism besides pentose phosphate pathway in RBL-2H3 cells. This novel insight into LPS cellular metabolism, provides some heuristic guidance for elucidating the underlying mechanism of LPS-mediated disease.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  GC-MS; Lipopolysaccharides; Metabolomics; Rat basophilic leukemia

Mesh:

Substances:

Year:  2017        PMID: 29275087     DOI: 10.1016/j.cbi.2017.12.008

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  1 in total

1.  Comprehensive Evaluation of Lipopolysaccharide-Induced Changes in Rats Based on Metabolomics.

Authors:  Chunmei Geng; Yujin Guo; Changshui Wang; Changmeng Cui; Wenxiu Han; Dehua Liao; Pei Jiang
Journal:  J Inflamm Res       Date:  2020-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.